HomeInsightsStock Comparison

Jubilant Pharmova Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Jubilant Pharmova Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: May 25, 2025

Key Highlights

  • The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 1073 as of 23 May 15:30.
  • The P/E Ratio of Jubilant Pharmova Ltd changed from 4.4 on March 2020 to 116.5 on March 2024 . This represents a CAGR of 92.56% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Jubilant Pharmova Ltd changed from ₹ 3964 crore on March 2020 to ₹ 9056 crore on March 2024 . This represents a CAGR of 17.97% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Jubilant Pharmova Ltd for the Mar '25 is ₹ 1940 crore as compare to the Dec '24 revenue of ₹ 1830 crore. This represent the growth of 6% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Jubilant Pharmova Ltd for the Mar '25 is ₹ 353.9 crore as compare to the Dec '24 ebitda of ₹ 277.4 crore. This represent the growth of 27.58% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Jubilant Pharmova Ltd changed from ₹ 6 crore to ₹ 151.3 crore over 8 quarters. This represents a CAGR of 402.16% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The Dividend Payout of Jubilant Pharmova Ltd changed from 24.8 % on March 2020 to 251.58 % on March 2024 . This represents a CAGR of 58.94% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Jubilant Pharmova Ltd News Hub

News

Board of Jubilant Pharmova recommends final dividend

Jubilant Pharmova announced that the Board of Directors of the Company at its meeting held...

Read more

16 May 2025 14:12

News

Jubilant Pharmova jumps after reporting turnaround Q4 performance

Revenue from operations increased 9.7% YoY to Rs 1,915.80 crore in Q4 FY25. The company re...

Read more

16 May 2025 16:07

News

Jubilant Pharmova to hold board meeting

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 16 May 2...

Read more

02 May 2025 13:52

News

Jubilant Pharmova arm gets EIR from USFDA for Maryland facility

The US Food and Drug Administration (USFDA) had classified the inspection as voluntary act...

Read more

13 Mar 2025 10:18

News

Volumes spurt at Jubilant Pharmova Ltd counter

K E C International Ltd, Indian Bank, J B Chemicals & Pharmaceuticals Ltd, Birla Corporati...

Read more

13 Mar 2025 11:00

News

Jubilant Pharmova announces acquisition of 80% stake in JASMIN

Jubilant Biosys Innovative Research Services, Singapore (JBIRSPL), a subsidiary of Jubilan...

Read more

29 Jan 2025 09:03

Sun Pharmaceutical Industries Ltd News Hub

News

Board of Sun Pharmaceutical Industries appoints director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved...

Read more

23 May 2025 11:13

News

Sun Pharmaceutical Industries announces cessation of director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has noted th...

Read more

23 May 2025 11:14

News

Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quart...

Read more

23 May 2025 13:48

News

Sun Pharmaceuticals Industries AGM scheduled

Sun Pharmaceuticals Industries announced that the 33th Annual General Meeting(AGM) of the ...

Read more

23 May 2025 15:37

News

Board of Sun Pharmaceuticals Industries recommends final dividend

Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its...

Read more

22 May 2025 20:47

News

Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%

Sun Pharmaceutical Industries Ltd rose 2.83% today to trade at Rs 1733.95. The BSE Healthc...

Read more

13 May 2025 09:30

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Jubilant Pharmova Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Jubilant Pharmova Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Jubilant Pharmova Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Jubilant Pharmova Ltd is 17,102 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 403,868 Cr

What are the key factors driving the stock performance of Jubilant Pharmova Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Jubilant Pharmova Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jubilant Pharmova Ltd and Sun Pharmaceutical Industries Ltd?

As of May 25, 2025, the Jubilant Pharmova Ltd stock price is INR ₹1073.6. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1683.25.

How do dividend payouts of Jubilant Pharmova Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Jubilant Pharmova Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions